Literature DB >> 24771684

Association of patient characteristics with chemotherapy receipt among depressed and non-depressed patients with non-small cell lung cancer.

Donald R Sullivan1, Linda Ganzini, Ariel Lopez-Chavez, Christopher G Slatore.   

Abstract

Entities:  

Keywords:  Depression; Epidemiology; Lung Cancer; Race; Treatment Receipt

Mesh：

Substances：

Year:  2014        PMID： 24771684      PMCID： PMC4208937          DOI： 10.1002/pon.3528

Source DB:  PubMed          Journal:  Psychooncology        ISSN： 1057-9249            Impact factor:   3.894


× No keyword cloud information.
  18 in total

1.  Racial differences in the treatment of early-stage lung cancer.

Authors:  P B Bach; L D Cramer; J L Warren; C B Begg
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

Review 2.  Racial and ethnic disparities in the receipt of cancer treatment.

Authors:  Vickie L Shavers; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2002-03-06       Impact factor: 13.506

3.  NCCN Non-Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network.

Authors:  D S Ettinger; J D Cox; R J Ginsberg; R Komaki; M G Kris; R B Livingston; D J Sugarbaker
Journal:  Oncology (Williston Park)       Date:  1996-11       Impact factor: 2.990

4.  Who gets chemotherapy for metastatic lung cancer?

Authors:  C C Earle; L N Venditti; P J Neumann; R D Gelber; M C Weinstein; A L Potosky; J C Weeks
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

5.  Do racial or socioeconomic disparities exist in lung cancer treatment?

Authors:  Relin Yang; Michael C Cheung; Margaret M Byrne; Youjie Huang; Dao Nguyen; Brian E Lally; Leonidas G Koniaris
Journal:  Cancer       Date:  2010-05-15       Impact factor: 6.860

6.  Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans.

Authors:  Sunny Wang; Melisa L Wong; Nathan Hamilton; J Ben Davoren; Thierry M Jahan; Louise C Walter
Journal:  J Clin Oncol       Date:  2012-03-26       Impact factor: 44.544

7.  The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel.

Authors:  Thomas A Hensing; Amy H Peterman; Michael J Schell; Ji-Hyun Lee; Mark A Socinski
Journal:  Cancer       Date:  2003-08-15       Impact factor: 6.860

8.  Race and sex differences in the receipt of timely and appropriate lung cancer treatment.

Authors:  Lisa R Shugarman; Katherine Mack; Melony E S Sorbero; Haijun Tian; Arvind K Jain; J Scott Ashwood; Steven M Asch
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

9.  Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database.

Authors:  Brian E Lally; Ann M Geiger; James J Urbanic; Jerome M Butler; Stacy Wentworth; Michael C Perry; Lynn D Wilson; Janet K Horton; Frank C Detterbeck; Antonius A Miller; Charles R Thomas; A William Blackstock
Journal:  Lung Cancer       Date:  2008-10-02       Impact factor: 5.705

10.  Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States.

Authors:  Kathleen Lang; Martin D Marciniak; Doug Faries; Michael Stokes; Don Buesching; Craig Earle; Joseph Treat; Nathalie Morissette; David Thompson
Journal:  Lung Cancer       Date:  2008-07-22       Impact factor: 5.705
View more
  1 in total

1.  The Impact of Preexisting Mental Health Disorders on the Diagnosis, Treatment, and Survival among Lung Cancer Patients in the U.S. Military Health System.

Authors:  Jie Lin; Katherine A McGlynn; Corey A Carter; Joel A Nations; William F Anderson; Craig D Shriver; Kangmin Zhu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-08-26       Impact factor: 4.254
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.